p
roteinprotein
interact
play
central
role
biolog
process
thu
appeahng
target
innov
drug
design
develop
target
small
molecul
inhibitor
peptid
peptidomimet
repres
altern
protein
therapeut
carri
mani
disadvantag
chapter
describ
specif
proteinprotein
interact
suggest
novel
model
immun
signal
signal
chain
homooligomer
school
model
critic
cell
activ
mediat
multichain
immun
recognit
receptor
mirr
express
differ
cell
hematopoiet
system
unravel
longstand
mysteri
mirr
trigger
transmembran
signal
school
model
reveal
intrareceptor
transmembran
interact
interreceptor
cytoplasm
homointeract
univers
therapeut
target
divers
varieti
disord
mediat
immun
cell
assum
gener
principl
underli
mirrmedi
transmembran
signal
mechan
similar
school
model
apph
particular
receptor
mirr
famili
thu
import
applic
school
model
global
therapeut
strategi
target
key
proteinprotein
interact
involv
mirr
trigger
transmembran
signal
transduct
may
use
treat
divers
set
immunemedi
diseas
assum
clinic
knowledg
therapeut
strategi
transfer
seemingli
dispar
disord
tcellmedi
skin
diseas
platelet
disord
combin
develop
novel
pharmacolog
approach
intriguingli
school
model
unravel
molecular
mechan
underli
abil
differ
human
virus
human
immunodefici
viru
cytomegaloviru
sever
acut
respiratori
syndrom
coronaviru
modul
andor
escap
host
immun
respons
also
demonstr
lesson
learn
firom
viral
pathogenesi
use
practic
ration
drug
design
applic
model
platelet
collagen
receptor
signal
alreadi
led
develop
novel
concept
platelet
inhibit
invent
new
platelet
inhibitor
thu
prove
suggest
hypothesi
highhght
import
broad
perspect
school
model
develop
new
target
strategi
specif
proteinprotein
interact
respons
function
numer
process
cell
constitut
foundat
major
cell
recognit
prolifer
growth
differenti
program
cell
death
signal
transduct
health
diseas
seem
almost
everi
import
pathway
includ
critic
influenc
proteinprotein
interact
ubiquit
natur
interact
knowledg
inappropri
proteinprotein
bind
lead
diseas
specif
control
inhibit
andor
modul
interact
provid
promis
novel
approach
ration
drug
design
reveal
recent
progress
design
inhibitori
antibodi
peptid
small
molecul
number
recent
review
address
topic
thu
reveal
inform
specif
proteinprotein
interact
particular
pathway
ie
transmembran
signal
provid
target
gener
new
drug
multichain
immun
recognit
receptor
mirr
recogn
foreign
antigen
initi
varieti
biolog
respons
exampl
mirr
includ
tcell
receptor
tcr
complex
bcell
receptor
bcr
complex
fc
receptor
eg
fceri
fcari
fcyri
fcyriii
nk
receptor
eg
immunoglobulin
ig
like
transcript
leukocyt
iglik
receptor
ilt
lir
respect
signal
regulatori
protein
sirp
dendrit
cell
immunoactiv
receptor
dcar
myeloid
dnax
adapt
protein
kd
associ
lectin
novel
immunetyp
receptor
nitr
trigger
receptor
express
myeloid
cell
trem
platelet
collagen
receptor
glycoprotein
vi
gpvi
mirrmedi
transmembran
tm
signal
transduct
play
import
role
health
diseas
make
receptor
attract
target
ration
intervent
varieti
immun
disord
thu
futur
therapeut
strategi
depend
detail
understand
molecular
mechan
underli
mirr
trigger
subsequ
tm
signal
transduct
member
mirr
famili
multisubunit
complex
form
associ
recognit
subunit
signaltransduc
subunit
contain
cytoplasm
cyto
domain
immunoreceptor
tyrosinebas
activ
motif
itam
yxxm
motif
found
cyto
domain
see
chapter
associ
rest
cell
mostli
driven
noncoval
tm
interact
recognit
signal
compon
play
key
role
receptor
assembl
integr
see
also
crosslinkingof
receptor
ligand
bind
result
phosphoryl
itamyxxm
tyrosin
trigger
elabor
intracellular
signal
cascad
extracellular
ec
recognit
antigenligand
sequenc
biochem
event
ensu
phosphoryl
itamsyxxm
understood
signific
detail
howev
molecular
mechan
link
ec
antigen
ligandinduc
cluster
mirr
ligandbind
subunit
intracellular
phosphoryl
signal
subunit
longstand
unsolv
mysteri
also
unknown
put
mechan
explain
intrigu
abil
immun
cell
discern
differenti
respond
slightli
differ
ligand
imped
advanc
understand
immun
respons
develop
novel
pharmacolog
approach
even
import
potenti
transfer
clinic
knowledg
experi
therapeut
strategi
seemingli
dispar
immun
disord
despit
numer
model
mirrmedi
tm
signal
transduct
suggest
particular
mirr
eg
tcr
bcr
fcr
nk
receptor
etc
current
model
fulli
explain
ligandinduc
tm
signal
transduct
commenc
molecular
level
consequ
model
mostli
descript
reveal
clinic
import
potenti
point
therapeut
intervent
addit
gener
model
mirrmedi
immun
cell
activ
suggest
thu
prevent
potenti
transfer
therapeut
strategi
seemingli
dispar
immun
disord
recendi
develop
novel
mechanist
model
school
model
describ
crucial
proteinprotein
interact
underli
molecular
mechan
mirr
trigger
tm
signal
fig
see
also
chapter
chapter
describ
specif
interact
new
model
propos
format
compet
mirr
signal
subunit
oligom
driven
homooligomer
signal
subunit
necessari
suffici
trigger
receptor
induc
transmembran
tm
signal
transduct
downstream
sequenc
see
chapter
detail
interchain
interact
intermedi
shown
light
gray
arrow
reflect
transit
state
immunoreceptor
tyrosinebas
activ
motif
itam
shown
gray
rectangl
circular
arrow
indic
ligandinduc
receptor
reorient
phosphat
group
shown
gray
circl
small
solid
black
arrow
indic
specif
intersubunit
heteroand
homointeract
tm
cytoplasm
cyto
domain
respect
within
model
mirr
trigger
signal
outcom
ligandinduc
interplay
three
key
proteinprotein
interact
antigenligandmirr
interact
intrareceptor
tm
interact
interreceptor
cyto
homointeract
b
two
interact
consid
new
therapeut
target
c
tm
interact
mirr
antigenrecogn
signaltransduc
subunit
target
play
import
role
receptor
assembl
integr
rest
cell
cyto
homointeract
mirr
signal
subunit
target
ii
repres
main
drive
forc
mirr
triggeringsign
therapeut
target
reveal
model
treatment
divers
immun
disord
mediat
mirr
assum
similar
structur
architectur
mirr
dictat
similar
mechan
mirr
trigger
subsequ
tm
signal
transduct
model
suest
target
similar
seemingli
unrel
diseas
build
structur
basi
develop
novel
pharmacolog
approach
well
transfer
clinic
knowledg
experi
therapeut
strategi
variou
immun
disord
addit
significantli
improv
understand
immunomodulatori
activ
human
virus
human
immunodefici
viru
hiv
human
cytomegaloviru
cmv
sever
acut
respiratori
syndrom
coronaviru
sarscov
human
tcell
leukemia
type
viru
assum
lesson
learn
viral
pathogenesi
use
develop
new
therapeut
approach
import
applic
hypothesi
gener
pharmaceut
approach
may
use
treat
divers
immunemedi
diseas
antigen
antimirr
antibodi
eg
antitcrp
tcr
anti
g
antibodi
bcr
lead
receptor
cluster
coupl
multistep
structur
reorgan
driven
homoougomer
mirr
signal
subunit
fig
la
ligandinduc
mirr
cluster
lead
receptor
reorient
format
dimericoligomer
intermedi
signal
chain
differ
receptor
unit
start
transhomointeract
form
signal
oligom
fig
la
stage
upon
format
signal
ougom
protein
tyrosin
kinas
phosphoryl
tyrosin
residu
itam
locat
cyto
tail
mirr
signal
subunit
lead
gener
intracellular
activ
signal
dissoci
signal
oligom
intern
engag
mirr
hgandbind
subunit
fig
la
stage
signal
oligom
interact
signal
subunit
nonengag
receptor
result
format
higherord
signal
oligom
thu
propag
amplifi
activ
signal
result
intern
nonengag
mirr
recognit
subunit
fig
la
stage
introduc
homotyp
interact
mirr
signahng
subunit
one
key
interact
involv
mirr
trier
tm
signahng
plausibl
easili
testabl
school
model
defin
process
outcom
interplay
three
major
drive
forc
tabl
antigenugandmirr
interact
interact
cluster
two
mirr
suffici
proxim
correct
permiss
rel
orient
initi
homointeract
particular
mirr
signal
subunit
intrareceptor
tm
interact
interact
stabil
maintain
receptor
integr
rest
cell
balanc
oppos
interact
interreceptor
cyto
homointeract
stimul
cell
thu
help
discrimin
ugandsantigen
function
abil
trigger
mirr
induc
cellular
activ
signal
interreceptor
homointeract
interaaion
cyto
domain
mirr
signal
subunit
lead
format
ougomer
signal
structur
thu
trigger
phosphoryl
itam
initi
signal
cascad
thu
school
model
reveal
last
two
key
interact
mirr
triggeringsign
new
therapeut
target
fig
ic
antigenligandmirr
interact
gener
low
affin
micromolar
rang
rapid
associ
dissoci
kinet
review
exampl
tcr
low
affin
bind
combin
fast
kinet
allow
immun
cell
recogn
discrimin
varieti
antigensligand
high
specif
select
sensit
order
respond
varieti
ofbiolog
respons
consid
ec
tm
region
mirr
wellord
receptor
segment
mirr
signal
cyto
domain
recendi
shown
repres
novel
class
intrins
disord
protein
import
intrigu
question
rais
mirr
transduc
highli
order
inform
antigen
recognitiondiscrimin
outsid
cell
cell
membran
intracellular
biochem
event
thu
trigger
specif
pathway
result
specif
function
outcom
despit
intens
studi
mirrmedi
tm
signal
transduct
model
answer
question
even
import
mechanist
explain
signahng
start
school
model
see
also
chapter
intriguingli
three
proteinprotein
interact
name
antigenugandmirr
ec
interact
well
intrareceptor
tm
heterointeract
interreceptor
cyto
homointeract
fig
ib
tabl
fall
within
similar
micromolar
affin
rang
character
rel
rapid
kinet
conjug
wellbalanc
system
interprotein
interact
provid
ideal
basi
explain
molecular
mechan
abihti
mirr
transduc
extracellular
inform
recognit
differ
ligandsantigen
cell
membran
translat
differ
activ
signal
thu
trigger
differ
intracellular
pathway
result
differ
cell
respons
within
model
mirrgener
intracellular
activ
signal
combinatori
natur
involv
multipl
compon
format
differ
compet
mirr
signaung
subunit
oligom
see
also
chapter
differ
itam
tyr
phosphoryl
pattern
system
also
explain
mechanist
high
specif
select
sensit
immun
cell
recognit
discrimin
differ
antigensligand
recognitiondiscrimin
result
differ
function
outcom
particularli
import
tcr
four
differ
signal
subunit
name
cdsi
known
play
differ
role
tcell
biolog
see
chapter
addit
contrast
mirr
signal
subunit
three
itam
provid
differenti
tyrosin
phosphoryl
pattern
respons
differ
ligand
initi
differ
intracellular
signal
pathway
thu
within
model
tcrmediat
signal
cell
activ
highest
combinatori
potenti
compar
mirr
explain
high
variabl
distinct
tcrtrigger
intracellular
signal
pathway
therefor
distinct
tcell
function
respons
depend
natur
stimulu
see
also
chapter
interact
tm
helic
recognit
signal
mirr
subunit
maintain
receptor
integr
unstimul
cell
determin
rel
posit
subunit
receptor
complex
angl
distanc
etc
thu
dictat
overal
geometri
topolog
mirr
within
school
model
overal
structur
architectur
ie
geometri
topolog
mirr
dictat
maintain
tm
interact
mirr
recognit
signal
subunit
fig
see
also
chapter
combin
requir
initi
interreceptor
homointeract
mirr
signal
subunit
fig
impos
sever
restraint
multival
antigenligandinduc
mirr
trigger
tabl
see
also
chapter
suffici
interreceptor
proxim
mirr
dimersoligom
correct
permiss
rel
orient
receptor
mirr
dimersoligom
long
enough
durat
mirrligand
interact
gener
correl
strength
affinityavid
ligand
suffici
lifetim
individu
receptor
mirr
dimersougom
import
factor
product
mirr
trigger
tm
signal
strongli
support
grow
bodi
evid
describ
detail
chapter
book
briefli
note
restraint
impos
model
play
especi
import
role
first
stage
mirr
trigger
fig
point
spatial
structur
tempor
requir
correct
rel
orient
suffici
proxim
long
enough
durat
mirrligand
interact
lifetim
mirr
dimersoligom
fulfil
favor
initi
transhomointeract
mirr
signal
subunit
format
compet
signal
subunit
oligom
requir
fulfil
final
decisionmak
point
form
mirr
dimersoligom
may
dissoci
ligand
remain
signalingincompet
andor
break
apart
initi
monomer
receptor
complex
also
stage
sughdi
differ
ligand
may
bring
two
mirr
differ
rel
orient
favor
homointeract
differ
signal
subunit
result
format
differ
signal
oligom
combin
thu
initi
distinct
signal
pathway
mechan
explain
abiuti
mirr
differenti
activ
varieti
signal
pathway
depend
natur
stimulu
school
model
fundament
differ
numer
model
previous
suggest
particular
mirr
sever
import
advantag
see
also
chapter
first
gener
mechanist
model
au
mirr
known
date
includ
tcr
bcr
fc
receptor
nk
receptor
ilt
lir
sirp
dcar
nitr
trem
gpvi
other
discov
futur
assum
gener
principl
underli
mirr
trigger
tm
signal
mechan
similar
mirr
school
model
easili
apph
particular
receptor
mirr
famili
first
model
base
specif
proteinprotein
interactionsbiochem
process
influenc
control
specif
inhibit
andor
modul
interact
provid
promis
novel
approach
ration
drug
design
reveal
recent
progress
design
inhibitori
antibodi
peptid
small
molecul
introduc
cyto
homointeract
mirr
signal
subunit
one
key
element
mirr
trier
signal
school
model
impos
function
import
restraint
tabl
see
also
chapter
suggest
molecular
mechan
vast
major
imexplain
immunolog
observ
accumul
date
see
also
chapter
unravel
molecular
mechan
underli
mirr
trigger
subsequ
tm
signal
model
suggest
uniqu
power
tool
studi
immun
respons
mean
control
andor
modul
see
also
chapter
base
specif
proteinprotein
interact
school
model
reveal
new
therapeut
target
fig
treatment
varieti
disord
mediat
immun
import
apphcat
school
model
similar
therapeut
strategi
target
key
proteinprotein
interact
involv
mirr
trigger
tm
signal
transduct
may
use
treat
divers
immunemedi
diseas
assum
clinic
knowledg
experi
therapeut
strategi
transfer
seemingli
dispar
immun
disord
use
develop
novel
pharmacolog
approach
gener
pharmaceut
approach
may
use
treat
divers
immun
disord
mention
previous
interreceptor
cyto
homointeract
school
model
reveal
specif
proteinprotein
interact
point
intervent
inhibit
andor
modul
mirrmedi
tm
signal
thu
inhibit
andor
modul
immun
respons
antigenligandreceptor
interact
wellknown
target
drug
design
develop
see
also
chapter
last
two
proteinprotein
interact
critic
involv
mirr
trieringsign
repres
promis
novel
therapeut
target
reveal
model
fig
suggest
model
control
inhibitionmodul
particular
interact
repres
mean
inhibitmodul
mirrmedi
tm
signal
specif
downstream
signal
pathway
thu
inhibitingmodul
immun
respons
ihi
use
ration
drug
design
develop
novel
strategi
treatment
varieti
diseas
medic
condit
involv
mirrmedi
signal
importantli
unravel
molecular
basi
mirr
trigger
signal
reveaung
specif
proteinprotein
interact
play
critic
role
mirrmedi
tm
signal
transduct
cell
activ
school
model
suggest
invalu
uniqu
power
tool
dissect
mechan
relat
cell
function
outcom
respons
antigenligand
studi
mani
import
aspect
viral
pathogenesi
see
also
chapter
chapter
demonstr
school
model
togeth
lesson
learn
fiom
viral
pathogenesi
use
practic
ration
drug
design
develop
new
therapeut
approach
treat
varieti
seemingli
unrel
disord
tcellmedi
skin
diseas
platelet
disord
sinc
first
publish
school
model
reveal
intramirr
tm
interact
import
therapeut
target
well
point
great
interest
studi
molecular
mechan
underli
mirrmedi
cell
respons
health
diseas
fig
notabl
model
provid
mechanist
explan
molecular
level
specif
process
behind
outsidein
mirr
signal
unclear
see
also
chapter
includ
molecular
mechan
action
therapeut
import
tcr
tm
peptid
first
introduc
manoho
et
al
mechan
underli
fusion
peptid
fp
induc
inhibit
antigendepend
tceu
activ
relev
latter
mechan
sinc
confirm
experiment
within
school
model
upon
antigenligand
stimul
intramirr
tm
interact
balanc
oppos
interact
intermirr
cyto
homointeract
repres
one
three
major
drive
forc
mirr
trigger
help
discrimin
ligandsantigen
function
abil
trier
mirr
induc
cellular
activ
signal
tabl
fig
target
transmembran
interact
mirr
recognit
signal
subunit
simplifi
graphic
illustr
molecular
mechan
underli
propos
intervent
transmembranetarget
agent
peptid
deriv
small
molecul
disruptor
proteinprotein
interact
etc
within
school
model
specif
blockad
transmembran
interact
recognit
signal
subunit
propos
result
predissoci
receptor
complex
thu
prevent
format
compet
signal
oligom
inhibit
antigendepend
immun
cell
activ
contrast
stimul
predissoci
mirr
crosslink
antibodi
signal
subunit
effect
accord
model
receptor
trigger
cell
activ
b
noteworthi
propos
strategi
use
inhibit
also
modul
mirrmedi
transmembran
signal
transduct
thu
modul
immun
respons
see
main
text
detail
abbrevi
symbol
figur
reprint
trend
pharmacol
sci
sigalov
ab
immun
cell
signal
novel
mechanist
model
reveal
new
therapeut
target
copyright
permiss
elsevi
ib
suggest
model
fig
ic
specif
blockad
disrupt
tm
interact
mirr
recognit
signal
subunit
caus
physic
function
disconnect
subunit
peptid
deriv
small
molecul
disruptor
proteinprotein
interact
sitespecif
mutat
similar
agentsmodif
use
affect
mirrtm
interact
note
context
physic
disconnect
mean
predissoci
rather
full
dissoci
subunit
absenc
stimulu
still
remain
togeth
antigenligand
stimul
predissoci
receptor
lead
reorient
cluster
recognit
signaung
subunit
result
signal
oligom
form
itam
tyr
residu
becom
phosphoryl
signal
cascad
initi
fig
contrast
predissoci
prevent
format
signal
ougom
signal
subunit
cluster
specif
antibodi
trigger
cell
activ
eg
antimirr
signal
antibodi
fig
tcr
antiigp
antibodi
bcr
antitcrp
antibodi
tcr
illustr
current
understand
mirr
structur
natur
specif
tm
interact
receptor
recognit
signal
subunit
allow
us
block
disrupt
proteinprotein
interact
also
modul
interact
sequencebas
approach
use
correspond
peptid
andor
deriv
strengtheningweaken
andor
select
disrupt
associ
particular
recognit
signal
subunit
might
allow
us
inhibit
rather
modul
ligandinduc
cell
respons
addit
select
function
disconnect
particular
signaung
subunit
recognit
partner
repres
invalu
tool
studi
mirrmedi
tm
signal
cell
activ
also
note
method
comput
design
synthesi
optim
tm
peptid
peptidomimet
well
highthroughput
screen
techniqu
search
relev
tm
mutat
small
molecul
disruptor
current
develop
wellestablish
make
propos
power
approach
feasibl
great
fundament
clinic
valu
suggest
tm
interact
recognit
signal
mirr
subunit
repres
extrem
import
point
control
mirr
trigger
cell
activ
sinc
use
school
model
design
tmtarget
agent
effect
inhibit
andor
modul
mirrmedi
tm
signal
fig
see
also
chapter
power
wellcontrol
influenc
upon
mirrmedi
cell
activ
control
immun
respons
relev
tmtarget
agent
particular
member
mirr
famili
readili
design
use
school
model
knowledg
structur
organ
receptor
exampl
includ
tm
peptid
tcr
nk
receptor
gpvi
test
inhibitmodul
relev
receptormedi
cell
respons
importandi
school
model
unravel
tmtarget
molecular
mechan
underli
abil
differ
human
virus
human
immunodefici
viru
cytomegaloviru
sever
acut
respiratori
syndrom
coronaviru
modul
andor
escap
host
immun
respons
also
demonstr
lesson
learn
viral
pathogenesi
use
practic
ration
drugdesign
exampl
success
prove
main
concept
school
modeldriven
tm
strategi
consid
detail
obvious
allow
us
effect
control
mirr
signal
therefor
immun
respons
mirrintrareceptor
tm
interaaion
repres
import
target
pharmacolog
intervent
first
reveal
suggest
school
model
assum
gener
therapeut
strategi
aim
disruptmodul
interact
mirr
may
use
exist
futur
treatment
seemingli
unrel
immun
diseas
word
accord
main
concept
school
model
specif
therapeut
agent
target
particular
mirr
involv
pathogenesi
relev
immun
disord
readili
design
use
basic
principl
structur
assembl
receptor
school
model
appli
particular
member
mirr
famili
excit
promis
exampl
use
school
modeldriven
tm
approach
fundament
clinic
applic
recendi
demonstr
couier
et
al
cover
detail
school
model
first
model
clearli
explain
molecular
mechan
action
tcr
tm
peptid
see
also
chapter
extend
concept
action
mechan
tm
peptid
mirr
mirrmedi
process
involv
viral
pathogenesi
select
agent
siest
predict
school
model
affect
mirr
tm
interact
thu
inhibit
modul
mirrmedi
immun
cell
activ
list
tabl
tm
peptid
capabl
inhibit
mirrmedi
cell
activ
first
report
antigenstimul
tcrmediat
tcell
activ
manolio
et
sinc
time
despit
extens
basic
clinic
studi
sever
tm
peptid
see
also
chapter
molecular
mechan
action
clinic
relev
peptid
elucid
school
model
first
introduc
vast
major
basic
clinic
find
report
tcr
tm
core
peptid
tcr
cp
tcr
mimic
peptid
repres
synthet
peptid
correspond
sequenc
tm
region
ligandbind
tcra
chain
critic
tcr
assembl
function
tm
region
shown
interact
tm
domain
signal
subunit
thu
maintain
integr
tcr
rest
tcell
briefli
suggest
school
model
fig
tabl
see
also
chapter
g
tcr
cp
compet
tcra
chain
bind
heteroand
homodim
respect
thu
result
disconnectionpredissoci
signal
subunit
remain
receptor
complex
fig
lead
inhibit
antigenbut
antibodymedi
tcr
trigger
cell
activ
fig
highught
propos
mechan
mechan
consist
experiment
clinic
data
report
date
tcr
mirr
tm
peptid
lipid
andor
sugar
recendi
new
experiment
evid
support
propos
mechan
inhibitori
action
tcra
cp
report
studi
clearli
shown
peptid
affect
tcr
assembl
cell
surfac
express
strikingli
kurosaka
et
demonstr
tcra
cp
coprecipit
ihi
find
perfectli
fit
molecular
explan
inhibitori
action
suggest
first
time
appli
school
modep
later
develop
within
model
compet
tcra
chain
tcra
cp
bind
signal
subunit
prevent
antigeninduc
format
relev
compet
signal
ougom
thu
inhibit
antigendepend
tcell
respons
fig
tabl
see
also
chapter
school
model
predict
mechan
inhibitori
action
appli
mirr
tm
peptid
correspond
tm
region
mirr
recognit
subunit
correspond
signal
subunit
recent
confirm
experiment
show
synthet
peptid
correspond
sequenc
tm
region
signal
e
subunit
abl
inhibit
immun
respons
vivo
tm
peptid
nk
cell
cytolyt
activ
vivo
tm
peptid
tabl
interestingli
model
suggest
molecular
explan
intrigu
phenomenon
recendi
report
collier
et
al
interpret
author
discrep
tm
peptid
activ
vitro
vivo
tcell
inhibit
shown
tm
peptid
impact
tcell
function
vitro
tm
peptid
use
report
vitro
experi
solubl
issu
three
tm
peptid
decreas
sign
inflamm
adjuvantinduc
arthriti
rat
model
vivo
inhibit
figur
propos
molecular
mechan
action
tcell
receptor
core
peptid
cp
fusion
peptid
fp
consid
close
similar
pattern
inhibit
tcell
activ
immunosuppress
activ
observ
cp
fp
school
model
reason
suggest
similar
molecular
mechan
action
peptid
within
school
model
peptid
compet
tcra
chain
bind
signal
subunit
thu
disrupt
transmembran
tm
interact
subunit
result
disconnect
predissoci
relev
signal
subunit
remain
receptor
complex
also
shown
inset
simplifi
axial
view
prevent
format
signal
oligom
upon
multival
antigen
stimul
thu
inhibit
antigenmedi
tcell
activ
contrast
stimul
predissoci
mirr
crosslink
antibodi
signal
subunit
still
lead
receptor
trigger
cell
activ
model
predict
mechan
inhibitori
action
appli
tcr
tm
peptid
correspond
tm
region
tcrap
recognit
subunit
subunit
well
addit
similar
mechan
propos
use
virus
cytomegaloviru
sever
acut
respiratori
syndromeassoci
coronaviru
pathogenesi
modul
host
immun
respons
immun
respons
within
school
model
data
reveal
discrep
vivo
vitro
experi
instead
consid
fact
first
direct
experiment
evid
abil
select
modul
mirrmedi
tm
signal
immun
respons
predict
context
tm
peptid
disconnect
correspond
signal
subunit
respect
remain
receptor
complex
tabl
therefor
antigen
stimul
result
format
relev
compet
signal
oligom
phosphoryl
itam
tyrosin
residu
prevent
initi
correspond
signaung
pathway
cell
respons
vitro
experi
author
use
interleukin
product
assay
tcell
prolifer
marker
tcell
activ
howev
previous
report
vitro
activ
studi
tcell
lack
andor
cytoplasm
domain
clearli
indic
antigenstimul
induct
cytokin
secret
tcell
prolifer
cell
intact
explain
absenc
inhibitori
effect
peptid
vitro
activ
assay
use
howev
vivo
defici
either
result
sever
immunodefici
disord
explain
inhibitori
effect
observ
vivo
studi
three
tm
peptid
experiment
data
success
prove
abil
select
physic
disconnect
specif
signal
subunit
use
mirr
tm
peptid
hne
school
model
result
select
function
disconnect
thu
provid
power
tool
studi
mirr
function
immun
cell
signal
even
importandi
also
confirm
predia
use
school
model
agent
target
specif
intramirr
tm
interact
design
inhibit
also
specif
modul
immun
respons
therefor
result
develop
novel
therapeut
strategi
varieti
inmiun
disord
similar
molecular
mechan
action
suest
school
model
mirr
tm
peptid
describ
andor
predict
inhibitorymodulatori
effect
mirrmedi
cell
activ
tabl
recent
school
modeldriven
tmtarget
strategi
success
appli
develop
novel
concept
platelet
inhibit
result
invent
new
class
platelet
inhibitor
fig
tabl
see
also
chapter
issu
cover
detail
summari
consid
high
therapeut
potenti
mirr
tm
peptid
illustr
clinic
result
tcr
cp
tabl
promis
result
peptid
tabl
jjg
school
model
repres
invalu
tool
develop
novel
pharmacolog
approach
target
mirr
tm
interact
contrast
mirr
singlechain
receptor
sr
character
structur
context
receptor
extracellular
recognit
domain
intracellular
signal
domain
locat
protein
chain
exampl
includ
receptor
tyrosin
kinas
rtk
tm
glycoprotein
consist
variabl
extracellular
ntermin
domain
singl
membran
span
domain
larg
cytoplasm
portion
compos
juxtamembran
domain
highli
conserv
tyrosin
kinas
domain
ctermin
regulatori
region
ligand
bind
believ
stimul
monomer
receptor
dimer
transautophosphoryl
defin
tyrosin
residu
intrins
kinas
activ
basic
principl
sr
signal
name
ligandinduc
receptor
dimerizationoligomer
transautophosphoryl
tabl
number
tyr
residu
cyto
signal
domain
consid
repres
common
mechan
trigger
tm
signal
transduct
vast
major
variou
receptor
dimer
sr
known
mosdi
driven
homointeract
receptor
tm
domain
find
reveal
interreceptor
tm
proteinprotein
interact
attract
point
pharmacolog
intervent
present
groavinglin
experiment
evid
indic
applic
tmtarget
strategi
inhibitmodul
sr
signal
might
repres
promis
therapeut
strategi
note
despit
appar
similar
use
tm
peptid
srand
mirrtarget
tm
strategi
basic
principl
molecular
mechan
underli
inhibit
andor
modul
sr
mirr
signal
use
tm
agent
total
differ
establish
field
sr
signal
srtarget
tm
peptidesag
blockdisrupt
modul
interreceptor
tm
interaaion
crucial
antigenligandinduc
receptor
oligomer
prevent
format
compet
receptor
ougom
wherea
mirrtarget
tm
peptidesag
suggest
school
model
see
also
chapter
affect
intramirr
tm
interact
recognit
signal
subunit
thu
prevent
upon
antigenligand
stimul
format
compet
mirr
signal
oligom
mirr
oligomersclust
term
mirr
recognit
subunit
signaung
subunit
affect
tm
agent
fundament
differ
molecular
mechan
action
srand
mirrtarget
tm
peptidesag
consid
srrelat
find
indirect
evid
fundament
clinic
relev
mirr
tmtarget
strategi
suggest
school
model
sever
exampl
use
tm
peptid
inhibit
sr
signal
describ
detail
ligand
bindinginduc
associ
tm
domain
propos
favor
product
dimer
intracellular
kinas
domain
promot
transautophosphoryl
studi
epiderm
growth
factor
eof
receptor
shown
synthet
peptid
encompass
tm
domain
receptor
inhibit
autophosphoryl
signal
pathway
cognat
receptor
peptid
thought
blockdisrupt
specif
tm
interact
therebi
inhibit
receptor
dimer
activ
use
differenti
epitop
tag
demonstr
receptor
form
homodim
tm
domain
vi
receptor
may
repres
part
interfac
receptor
dimer
shown
peptid
deriv
domain
inhibit
dimer
padrenerg
agonistpromot
stimul
adenylyl
cyclas
activ
contrast
peptid
base
sequenc
transmembran
domain
dopamin
receptor
didr
found
specif
inhibit
idr
bind
function
without
affect
receptor
oligomer
one
possibl
explan
find
addit
ugandstimul
dimer
receptor
correct
permiss
rel
orient
receptor
dimer
form
also
play
import
role
signal
import
rel
orient
shown
sr
exampl
egf
receptor
epo
receptor
tolllik
receptor
tlr
integr
membran
receptor
luxpq
presenc
tm
peptid
bound
idr
tm
domain
like
prevent
ugandinduc
format
receptor
dimer
correct
intermolecular
orient
thu
prevent
gener
activ
signal
anoth
exampl
srtarget
tm
inhibitori
peptid
short
peptid
sequenc
correspond
neu
rtk
tm
domain
also
report
independ
fold
membran
interact
fulllength
receptor
inhibit
transform
cell
vitro
vivo
gproteincoupl
receptor
gpcr
character
presenc
seven
tm
domain
repres
superfamili
protein
mediat
function
neurotransmitt
peptid
hormon
involv
viral
entri
percept
light
smell
tast
structur
analog
individu
tm
domain
gpcr
report
serv
potent
specif
receptor
inhibitor
peptid
sequenc
correspond
tm
domain
chemokin
receptor
also
call
fusin
alphachemokin
receptor
specif
chemokin
receptor
hiv
use
coreceptor
gain
entri
macrophag
demonstr
specif
inhibit
receptor
signal
vitro
replic
hivl
similarli
peptid
mimick
tm
domain
cholecystokinin
receptor
found
abolish
ligand
bind
signahng
receptor
thu
sequencebas
blockad
interreceptor
tm
protein
interact
appli
sr
signal
provid
indirect
evid
import
clinic
signific
intramirr
tmtarget
strategi
suggest
school
model
gener
term
viral
pathogenesi
process
viral
infect
lead
diseas
consequ
viral
infect
depend
number
viral
host
factor
affect
pathogenesi
infect
host
cell
envelop
virus
requir
fusion
viral
membran
host
cell
membran
fusion
mediat
viral
glycoprotein
gp
protein
anchor
viral
membran
fusion
glycoprotein
envelop
virus
typic
typei
integr
membran
protein
known
contain
sequenc
short
region
call
fusion
peptid
fp
requir
mediat
membran
fusion
region
interact
host
cell
membran
earli
stage
membran
fusion
process
despit
advanc
understand
major
principl
viral
fusion
mediat
fusion
glycoprotein
litd
known
role
function
modul
mirrmedi
tm
signal
transduct
section
focu
mirr
signalingrel
immunomodulatori
activ
recendi
report
hiv
cmv
suggest
school
model
molecular
mechan
underli
activ
affect
mirr
tm
interact
also
use
virus
illustr
point
describ
applic
model
pathogenes
two
virus
sarscov
also
demonstr
school
modeldriven
tm
strategi
togeth
lesson
learn
viral
pathogenesi
use
practic
ration
drug
design
develop
new
therapeut
approach
fp
found
n
terminu
hiv
envelop
glycoprotein
function
togeth
domain
fuse
virion
host
cell
membran
surprisingli
peptid
recent
shown
fusogen
activ
also
tcelltarget
immunomodulatori
activ
coloc
tcr
molecul
coprecipit
tcr
inhibit
antigenstimul
tcell
prolifer
proinflammatori
cytokin
secret
vitro
effect
specif
tcell
activ
via
pmaionomycin
mitogen
antibodi
affect
fp
fp
interfer
antigenpres
cell
function
mice
hiv
fp
show
immunosuppress
activ
inhibit
activ
arthritogen
tcell
autoimmun
diseas
model
adjuv
arthriti
reduc
diseaseassoci
interferoni
ifni
respons
close
match
find
experiment
data
gener
tcr
cp
suggest
mechanist
similar
underli
tcrtarget
hiv
fp
tcr
cp
activ
howev
tcr
cp
despit
ongo
studi
hiv
fp
molecular
mechan
immunomodulatori
action
peptid
elucid
school
model
first
appli
area
consid
close
similar
pattern
inhibit
tcell
activ
immunosuppress
activ
observ
fp
cp
school
model
reason
suggest
similar
molecular
mechan
action
tcr
tm
peptid
hiv
fp
fig
tabl
primari
sequenc
analysi
two
peptid
tabl
show
differ
primari
sequenc
similar
charg
polar
residu
distribut
pattern
two
posit
charg
residu
space
apart
cp
fp
amino
acid
cp
arg
ly
residu
known
mediat
interact
recognit
tcra
subunit
signal
subunit
importandi
fp
arginin
locat
ctermin
half
suest
sequenc
could
import
interact
tcr
figur
show
potenti
mode
action
cp
fp
propos
scfiool
model
see
also
tabl
briefli
cp
fp
compet
tcra
chain
bind
heteroand
homodim
respect
thu
result
tm
disconnectionpredissoci
signaungsubunit
remain
receptor
complex
fig
mechan
fp
action
suest
exist
interact
interfac
ctermin
half
peptid
within
model
peptid
prevent
format
signal
oligom
thu
inhibit
antigendepend
tcell
activ
fig
tabl
act
similarli
respect
tcr
cp
fig
tabl
howev
stimul
antibodi
predissoci
tcr
still
result
result
receptor
trigger
cell
activ
model
suggest
clinic
relev
antibodi
could
use
modul
affect
tcell
respons
hiv
infect
recendi
antibodi
use
success
hiv
therapi
augment
immun
activ
recent
studi
confirm
predict
molecular
mechan
immunomodulatori
activ
hiv
fp
final
note
propos
mechan
mechan
consist
experiment
data
immunomodulatori
action
hiv
fp
report
highli
specif
natur
inhibitor
fp
recent
report
block
entri
agent
isol
human
hemofiltr
design
viru
inhibitori
peptid
virip
repres
peptid
correspond
cproxim
region
importandi
shown
virip
direcdi
interact
fp
amino
acid
chang
increas
antiretrovir
activ
potenc
two
order
magnitud
thu
demonstr
usabl
effici
ration
peptid
design
approach
accord
school
model
tcr
tm
interact
repres
import
therapeut
target
immunemedi
diseas
also
point
hiv
intervent
molecular
mechan
reveal
model
use
ration
antivir
drug
design
develop
novel
antivir
therapi
anoth
applic
school
model
hiv
pathogenesi
relat
molecular
mechan
action
hiv
pathogen
factor
nef
key
protein
viral
replic
progress
diseas
sever
studi
shown
protein
interact
tcr
chain
mediat
downmodul
complex
notabl
nef
lower
threshold
activ
studi
show
nef
induc
transcript
array
gene
almost
ident
trigger
upon
exogen
stimul
tcr
nef
also
report
affect
tcell
activ
event
interact
within
lipid
raft
microenviron
induc
signal
transduct
via
recruit
signal
machineri
therebi
mimick
physiolog
cellular
mechan
initi
tcr
cascad
final
form
signal
complex
tcr
bypass
requir
antigen
initi
tcell
activ
thu
extent
tcell
activ
imprint
express
nef
matter
controversi
addit
although
know
nef
bind
tcr
chain
role
interact
mechan
use
nef
modul
tcell
activ
remain
unknown
importandi
similar
nef
exist
sever
discret
oligomer
speci
name
monom
dimer
trimer
within
model
nativ
oligomer
nef
may
crosslink
homodimer
chain
lead
format
multival
tcr
complex
shown
respons
sens
low
concentr
antigen
mechan
could
explain
observ
activ
sensit
tcell
nef
hand
nef
dimer
may
crosslink
homodim
permiss
rel
orient
promot
format
compet
signal
oligom
gener
activ
signal
fig
see
also
chapter
result
tabl
hiv
fp
tcr
coloc
uith
tcr
molecul
coprecipi
dissoci
signal
oligom
remain
receptor
complex
subsequ
intern
scfiool
model
suggest
oligom
interfac
andor
nef
involv
molecular
mechan
underli
immunomodulatori
effect
recendi
shown
nef
mutant
carri
mutat
target
conserv
residu
addit
lose
abil
oligomer
defect
major
histocompat
complex
class
mhct
downmodul
enhanc
viral
infect
suggest
oligomer
nef
may
critic
multipl
function
regard
suggest
propos
mechan
may
take
place
vivo
select
two
altern
pathway
may
possibl
depend
type
cell
infect
andor
cell
membran
lipid
content
thu
cyto
heterointeract
nef
interfac
cyto
homointeract
nef
oligom
may
repres
attract
target
design
antivir
agent
usabl
effici
scfiool
modeldriven
cyto
approach
later
demonstr
nefmedi
intern
surfac
depend
bind
nef
cyto
domain
target
molecul
respect
issu
cover
detail
coronaviru
sar
cov
etiolog
agent
sar
repres
lifethreaten
diseas
associ
mortal
recent
studi
total
patient
sar
enrol
shown
tlymphocyt
level
reduc
patient
respect
thu
one
suggest
viru
immunomodulatori
activ
activ
tcrtarget
tradit
view
fliv
diseas
cours
acut
hw
infect
character
massiv
rapid
tcell
loss
wherea
chronic
infect
character
persist
immun
activ
drive
viral
replic
tcell
deplet
thu
hiv
infect
thought
rel
indol
disrupt
tcell
eventu
lead
collaps
immun
function
sar
cov
notion
larg
base
measur
tcell
count
peripher
blood
despit
lack
direct
evid
reason
suggest
sarscov
tcrtarget
immunomodulatori
activ
specif
hiv
activ
might
especi
import
viru
entri
suppress
host
respons
viru
infect
like
envelop
virus
encod
class
viral
fusion
protein
hiv
ebola
avian
sarcoma
virus
sarscov
presum
use
membran
fusion
mechan
viral
entri
shown
sarscov
viral
spike
protein
class
viral
fusion
protein
respons
drive
viral
targetcel
membran
fusion
recendi
inhibitori
peptid
deriv
membraneproxim
heptad
repeat
region
protein
suggest
attract
basi
develop
therapeut
sar
put
sarscov
fp
also
identifi
n
terminu
sarscov
subunit
shown
use
synthet
peptid
fusogen
activ
sarscov
fp
appear
depend
amino
acid
sequenc
scrambl
peptid
render
unabl
partit
larg
unilamellar
vesicl
luv
assum
defin
secondari
structur
induc
fusion
leakag
luv
primari
sequenc
analysi
sarccov
fp
tcrcx
tm
domain
tcr
cp
show
differ
primari
sequenc
reveal
similar
charg
polar
residu
distribut
pattern
two
posit
charg
residu
space
apart
amino
acid
tabl
two
posit
charg
residu
critic
tcr
assembl
function
within
school
model
die
rilllk
rsmtltvqar
motif
tcr
cp
hiv
fp
tabl
respect
play
import
role
mimick
tcra
tm
region
therefor
inhibitori
activ
peptid
fig
tabl
intriguingli
sar
cov
fp
structur
motif
ktptlk
strikingli
similar
tcr
cp
tabl
consid
common
structur
featur
three
peptid
tcr
cp
sarscov
fp
hiv
fp
well
function
similar
hiv
fp
sar
fp
context
tcelltarget
activ
suggest
like
tcr
cp
hiv
fp
sarscov
fp
mimic
tcra
tm
domain
therefor
exhibit
inhibitori
effect
antigenmedi
tcr
tm
signal
tabl
context
school
model
molecular
mechan
inhibitori
action
sarscov
fp
similar
suggest
tcr
cp
hiv
fp
fig
tabl
hypothes
tcr
tm
interact
might
repres
point
sarscov
intervent
true
molecular
mechan
reveal
use
ration
antivir
drug
design
develop
novel
antivir
therapi
believ
futur
studi
experiment
prove
hypothesi
htlvl
type
c
complex
retroviru
infect
immort
human
vitro
associ
develop
adult
tcell
leukemialymphoma
atl
recent
observ
demonstr
immunomodulatori
abil
regulatori
protein
jj
suggest
role
tcell
activ
may
play
pathogenesi
consid
similar
htlvl
fp
nef
p
protein
respect
describ
structur
function
predict
relat
potenti
tcrtarget
activ
htlvl
fp
currendi
experiment
evid
predict
activ
despit
beuev
futur
studi
prove
hypothes
made
use
school
model
similarli
protein
ectodomain
htlvl
tm
protein
contain
ntermin
locat
fusion
peptid
sequenc
insert
target
cellular
membran
wellknown
critic
membran
fusion
activ
howev
contrast
hiv
fp
report
date
immunomodulatori
activ
htlvl
fp
primari
sequenc
analysi
two
fp
tabl
indic
differ
sequenc
reveal
interest
similar
charg
polar
residu
distribut
pattern
two
posit
charg
residu
space
apart
hiv
fp
htlvl
fp
amino
acid
consid
structur
similar
fp
fact
tcell
main
target
virus
reason
suggest
tcrtarget
immunomodulatori
activ
fp
propos
school
hiv
fp
tcr
cp
fig
tabl
potenti
mode
action
htlvl
involv
tm
competit
tcra
subunit
bind
subunit
thu
result
tm
disconnectionpredissoci
signal
subunit
remain
receptor
complex
fig
tabl
hiv
fp
mechan
htlvl
fp
action
suest
exist
interact
interfac
ctermin
half
peptid
within
model
peptid
prevent
format
signalingcompet
oligom
thu
inhibit
antigendepend
tcell
activ
act
similarli
respect
tcr
cp
hiv
fp
fig
tabl
howev
stimul
antibodi
predissoci
tcr
still
result
fig
receptor
trigger
cell
activ
hiv
infect
model
suggest
clinic
relev
antibodi
ie
could
use
modul
affect
tcell
respons
htlvl
infect
summari
propos
new
hypothesi
consid
larg
unexplor
immunomodulatori
role
fp
htlvl
infect
pathogenesi
atl
true
hypothesi
gener
new
therapeut
target
opportun
also
suggest
current
futur
clinic
knowledg
experi
therapeut
strategi
potenti
transfer
respect
hivand
htlvlrelat
medic
condit
protein
small
oncoprotein
shown
multipl
function
express
demonstr
induc
nuclear
factor
activ
tcell
nfat
increas
calcium
releas
transcript
factor
stat
activ
tcell
suggest
may
alter
tcell
signal
interestingli
import
viral
infect
quiescent
human
peripher
blood
lymphocyt
pbl
establish
persist
infect
rabbit
despit
distinct
structur
retrovir
accessori
protein
htlvl
hivnef
abl
modul
tcrmediat
signal
play
critic
role
enhanc
viral
infect
primari
lymphocyt
infect
anim
recent
report
could
complement
effect
nef
infect
cell
express
surfac
macrophag
also
clone
jurkat
cell
express
highest
level
p
found
exhibit
rapid
rate
cell
prolifer
parent
cell
similarli
hivnef
protein
upon
engag
tcr
reloc
interfac
tceu
antigenpres
cell
defin
immunolog
synaps
nef
recruit
nef
potenti
tcr
signal
dampen
summari
target
tcrmediat
signal
seem
share
featur
hiv
virus
reflect
probabl
similar
evolutionari
pathway
toward
adapt
host
immun
respons
thu
possibl
similar
molecular
mechan
mayb
involv
tcrtarget
strategi
use
nef
p
modul
tcrmediat
signaung
pathway
true
hypothesi
gener
new
therapeut
target
ie
proteinprotein
interact
interfac
potenti
tcrrelat
partner
opportun
similar
suggest
hiv
nef
escap
nk
cellmedi
surveil
human
cmv
interfer
express
ligand
infect
cell
addit
viru
may
keep
nk
inhibitori
receptor
engag
preserv
human
leukocyt
antigen
hla
class
molecul
limit
role
antigen
present
despit
consider
progress
field
number
issu
regard
involv
nk
receptor
innat
immun
respons
human
cmv
remain
unresolv
recent
direct
interact
human
cmv
tegument
protein
nk
cell
activ
receptor
report
shown
bind
specif
function
surprisingli
recognit
lead
nk
cell
activ
instead
result
gener
inhibit
mediat
dissoci
signal
subunit
receptor
complex
result
diminish
activ
signal
loss
abil
nk
cell
kill
normal
tumor
virusinfect
within
context
school
model
report
action
human
protein
may
due
potenti
impact
tm
interact
lead
disconnect
dissoci
subunit
would
prevent
format
signalingcompet
oligom
upon
ligand
stimul
consequ
inhibit
nk
cell
cytolyt
activ
fig
tabl
manner
similar
respect
inhibitori
action
tcr
cp
fig
tabl
primari
sequenc
analysi
ntermin
end
show
exist
multipl
posit
neg
charg
amino
acid
residu
tabl
region
possibl
contain
sequenc
mimic
tm
domain
arg
asp
residu
respect
known
mediat
interact
recognit
chain
signal
subunit
see
also
chapter
howev
experiment
studi
need
confirm
propos
mechan
gener
issu
relat
viral
pathogenesi
context
mirr
tm
signaung
cover
detail
chapter
section
briefli
describ
sever
import
lesson
learn
school
modelrev
similar
molecular
mechan
underli
viral
pathogenesi
mirr
signalingtarget
immunomodulatori
viral
activ
import
viral
immun
escap
also
consid
strike
similar
molecular
mechan
basic
structur
principl
suggest
model
explain
immunomodulatori
effect
viral
fusion
accessori
protein
synthet
agent
affect
intraor
intermirr
proteinprotein
interact
tm
cyto
miueu
respect
seem
gener
virus
use
tmtarget
immunomodulatori
activ
fusion
protein
mosdi
viru
entri
suppress
host
immun
respons
wherea
modul
cyto
interact
use
accessori
protein
hiv
nef
p
play
role
viral
repuc
enhanc
viral
infect
host
thu
improv
understand
mirr
signalingtarget
immunomodulatori
viral
activ
might
allow
us
reveal
novel
target
stage
viral
pathogenesi
beuev
lesson
learn
viral
pathogenesi
context
school
model
immun
signal
import
understand
molecular
mechan
use
virus
infect
host
escap
inmiun
respons
also
believ
lesson
fundament
clinic
valu
know
molecular
mechan
inhibitori
action
mirr
tm
peptid
tcr
tm
peptid
nk
tm
peptid
gpvi
tm
peptid
suest
school
model
also
know
mechan
like
use
vivo
hiv
fp
also
predict
school
model
fusion
protein
virus
sarscov
fp
suppress
host
immun
consid
high
specif
effici
viral
agent
inhibit
immun
receptor
combin
current
knowledg
proteinprotein
interact
underli
process
use
modern
wellestablish
comput
bioinformat
synthet
methodolog
design
produc
highli
specif
effect
tmtarget
agent
abl
affect
specif
tm
interact
target
mirr
suppress
andor
modul
mirrmedi
immun
respons
agent
would
great
fundament
clinic
valu
similar
conclus
drawn
abil
use
school
model
immun
signal
lesson
learn
current
knowledg
cytotarget
viral
strategi
design
produc
effici
specif
cytotarget
agent
accordingtotheschoolmodel
tcrcp
fp
predict
sarscov
fp
fp
affect
simuar
tcr
tm
interact
fig
tabl
primari
sequenc
analysi
peptid
tabl
show
differ
primari
sequenc
strike
similar
charg
polar
residu
distribut
pattern
suggest
comput
approach
combin
molecular
mechan
action
peptid
reveal
school
model
use
ration
design
effect
immunomodulatori
tmtarget
peptid
gener
wellknown
principl
design
tm
peptid
abil
insert
membran
might
readili
use
stage
suggest
school
model
fig
tmtarget
agent
inhibit
mirrmedi
cell
activ
induc
antigenligand
antibodi
mirr
signal
subunit
inde
shown
tcr
cp
hiv
fp
tm
peptid
inhibit
antigenmedi
tcell
activ
wherea
stimul
antibodi
presenc
peptid
still
result
function
cell
respons
entir
similar
consider
appli
viral
fp
sarscov
fp
fr
thu
school
model
suggest
antibodi
mirr
signal
subunit
use
immunotherapeut
modul
affect
immun
cell
respons
viral
infect
tcr
consid
select
abil
physic
importantli
function
disconnect
particular
andor
signal
subtmit
remain
receptor
use
relev
tm
peptid
basic
principl
school
model
tcr
signal
fig
design
synthes
use
peptid
power
tool
dissect
fine
molecular
mechan
viral
pathogenesi
context
tcr
signal
two
unrel
envelop
virus
hiv
human
cmv
use
similar
mechan
modul
host
immun
respons
mediat
two
function
differ
mirrstcr
predict
school
model
sarscov
also
use
similar
mechan
viru
infect
intriguingli
shown
tabl
similar
posit
charg
residu
distribut
pattern
two
arg
andor
ly
residu
space
apart
amino
acid
observ
fp
seemingli
unrel
virus
hiv
lassa
viru
lasv
lymphocyt
choriomening
viru
lcmv
mopeia
viru
mopv
tacarib
viru
tacv
thu
like
similar
gener
immunomodulatori
mechan
use
viral
possibl
nonvir
pathogen
see
also
chapter
addit
hiv
fp
promis
appli
similar
strategi
block
viral
entri
use
agent
abl
interact
directli
fp
virus
damag
integr
vessel
wall
result
exposur
subendotheli
extracellular
matrix
trigger
platelet
adhes
aggreg
consequ
process
format
thrombu
prevent
blood
loss
site
injuri
lead
occlus
irrevers
tissu
damag
infarct
diseas
vessel
despit
intens
research
effort
antithrombot
drug
discoveri
develop
uncontrol
hemorrhag
still
remain
common
side
effect
associ
antithrombot
drug
currendi
use
major
physiolog
function
platelet
hemostasi
prevent
bleed
effect
aspirin
establish
also
involv
patholog
variant
thrombosi
platelet
also
play
critic
role
coronari
arteri
diseas
stroke
evidenc
welldocu
benefit
antiplatelet
therapi
platelet
adhes
aggreg
activ
induc
collagen
critic
depend
upon
engag
cluster
gpvi
type
transmembran
platelet
glycoprotein
kda
major
signal
receptor
collagen
platelet
see
also
chapter
gpvi
intrins
signal
capac
signal
achiev
associ
signal
partner
fcri
chain
select
inhibit
gpvi
andor
signal
thought
expert
field
inhibit
thrombosi
without
affect
hemostat
plug
format
thu
provid
new
therapeut
strategi
fight
plateletmedi
diseas
see
also
chapter
jj
contrast
antithrombot
drug
current
use
gpvi
receptorspecif
inhibitor
repres
ideal
class
clinic
suitabl
antithrombot
howev
despit
intens
studi
cpvifcri
receptor
complex
mechan
gpvi
signal
known
recent
school
model
introduc
appli
gpvi
trigger
tm
signal
transduct
result
develop
novel
concept
platelet
inhibit
invent
new
platelet
inhibitor
within
promis
antithrombot
strategi
invent
inhibitor
propos
use
preventiontreat
thrombosi
medic
condit
involv
collageninduc
platelet
activ
aggreg
well
product
drugcoat
medic
devic
within
school
model
gpvimedi
platelet
activ
result
interplay
cpvifcri
tm
interact
associ
two
tm
asp
residu
fcri
homodim
tm
arg
residu
gpvi
maintain
receptor
integr
platelet
basal
condit
homointeract
fcri
subunit
lead
initi
signal
respons
tabl
fig
bind
multival
collagen
ligand
two
gpvtfcri
receptor
complex
push
receptor
cluster
rotat
adopt
appropri
orient
rel
fig
step
point
transhomointeract
fcri
molecul
initi
upon
format
fcri
signal
oligom
srcfamili
kinas
fyn
lyn
phosphoryl
tyrosin
residu
fcri
itam
lead
tm
transduct
activ
signal
fig
step
dissoci
fcri
oligom
downmodul
engag
gpvi
subunit
fig
step
later
dissoci
oligomer
fcri
chain
interact
fcri
subunit
nonengag
gpvifcri
complex
result
format
higherord
signal
oligom
subsequ
phosphoryl
thu
provid
later
signal
propag
amplif
shown
preform
oligomer
receptor
complex
describ
berlanga
et
al
model
suggest
basal
condit
overal
geometri
receptor
dimer
keep
fcri
chain
apart
wherea
stimul
collagen
result
breakag
gpvigpvi
extracellular
interact
reorient
signal
fcri
homodim
thu
bring
close
proxim
appropri
rel
orient
permiss
initi
fcri
homointeract
fig
thu
school
model
highught
strike
similar
data
coexist
monoand
multival
tcr
gpvi
rest
tcell
nonstimul
platelet
respect
suest
similar
molecular
explan
answer
import
intrigu
question
rais
studi
observ
basal
tcr
gpvi
oligomer
lead
receptor
trigger
subsequ
tcell
platelet
activ
respect
wherea
agonistinduc
receptor
crosslinkingclusteringdo
see
also
chapter
suggest
bind
collagen
trigger
gpvimedi
signal
cascad
molecular
level
school
model
collageninduc
gpvi
signal
reveal
gpyifcri
tm
interact
novel
therapeut
target
prevent
treatment
plateletmedi
thrombot
specif
blockad
disrupt
interact
caus
physic
function
disconnect
subunit
fig
tabl
antigen
stimul
predissoci
receptor
complex
lead
cluster
gpvi
fcri
subunit
result
fcri
signal
oligom
form
itam
tyr
residu
becom
phosphoryl
signal
cascad
initi
agent
target
gpvlfcri
tm
interact
may
thu
repres
novel
class
platelet
inhibitor
includ
limit
peptid
peptid
deriv
composit
nonpeptid
small
molecul
inhibitor
preliminari
experiment
result
provid
support
novel
concept
platelet
inhibit
demonstr
incub
whole
blood
sampl
peptid
correspond
tm
domain
gpvi
glyasnleuvalargilecysleuglyalav
final
concentr
prior
addit
collagen
igml
convubdn
ngml
lead
reduct
percentag
pselectinposit
platelet
express
platelet
activ
marker
pselectin
sigalov
ab
barnard
mr
freling
al
michelson
ad
unpubhsh
result
effect
specif
platelet
activ
via
adp
im
affect
peptid
assum
school
model
peptid
penetr
platelet
membran
competit
bind
fcri
tm
domain
thu
replac
gpvi
receptor
interact
signal
fcri
subunit
result
predissoci
gpvifcri
receptor
complex
fig
notabl
control
peptid
contain
singl
amino
acid
substitut
arg
ala
display
inhibitori
activ
phenomenon
predict
school
model
sinc
peptid
compet
gpvi
bind
fcri
tm
milieu
conclus
combin
basic
principl
school
model
recendi
report
comput
design
peptid
target
tm
helix
sequencespecif
manner
wellestablish
techniqu
search
relev
tm
mutat
small
molecul
disruptor
well
synthes
optim
tm
peptid
peptidomimet
open
new
avenu
design
novel
platelet
inhibitor
make
propos
strategi
feasibl
great
fundament
cunic
valu
combin
breakthrough
scientif
idea
advanc
differ
field
high
market
potenti
suggest
technolog
open
new
perspect
innov
antithrombot
drug
discoveri
develop
anoth
interest
applic
school
model
challeng
predict
power
describ
prognosi
relat
use
tmand
possibl
cytotarget
agent
therapeut
treat
inflammatori
bowel
diseas
ibd
briefli
intestin
inflamm
colit
sever
combin
immunodefici
scid
mice
recendi
shown
character
signific
increas
also
demonstr
neutral
mab
treatment
prevent
ameuor
develop
coliti
primarili
inhibit
expans
andor
infiltr
pathogen
tcell
colon
secondarili
inhibit
develop
pathogen
thl
cell
author
conclud
target
signal
pathogen
tcell
may
use
strategi
treatment
thlmediat
chronic
intestin
inflamm
crohn
diseas
surest
tmtarget
agent
tm
peptid
design
use
school
modeldriven
tmtarget
strategi
specif
activ
therefor
use
promis
therapeut
prevent
andor
treat
ibd
tabl
futur
studi
prove
disprov
hypothesi
mention
cyto
domain
vast
major
mirr
signal
subunit
name
c
igot
igp
fcri
recent
shown
repres
new
class
intrins
disord
protein
idp
see
also
chapter
definit
idp
nativ
unfold
intrins
unstructur
protein
lack
welldefin
order
structur
physiolog
condit
vitro
ie
neutral
ph
room
temperatur
highli
flexibl
random
coillik
conform
nativ
function
state
mani
protein
known
involv
cell
signal
addit
intrins
disord
region
human
plasma
membran
protein
recendi
demonstr
preferenti
occur
cytoplasm
segment
final
suggest
protein
phosphoryl
one
critic
obligatori
event
cell
signal
occur
predominandi
within
intrins
disord
protein
region
major
assumpt
flexibl
randomcoil
conform
mirr
signal
subunit
cyto
domain
play
import
role
mirr
trigger
tm
signal
also
suggest
cyto
domain
mirr
signal
subunit
studi
far
eg
dap
dap
fcerip
idp
well
futur
studi
prove
disprov
hypothesi
surprisingli
intrins
disord
cyto
domain
studi
exist
physiolog
condit
specif
oligom
mostli
dimer
discov
publish
even
interestingli
idp
undergo
transit
disord
order
state
upon
dimer
specif
dimer
distinct
nonspecif
aggreg
behavior
seen
mani
system
find
oppos
gener
accept
view
behavior
idp
provid
first
evid
exist
specif
dimer
interact
idp
speci
thu
open
new
hne
research
new
quickli
develop
field
idp
unusu
uniqu
discov
biophys
phenomenon
found
gener
phenomenon
cyto
domain
studi
work
led
hypothes
homointeract
mirr
signal
subunit
repres
miss
piec
puzzl
mirr
trigger
tm
signal
transduct
develop
scfiool
model
see
also
chapter
sinc
first
publish
school
model
reveal
intermirr
cyto
homointeract
import
therapeut
target
well
point
great
interest
studi
molecular
mechan
underli
mirrmedi
cell
respons
health
diseas
fig
thc
modcl
upon
antigenugand
stimul
interact
repres
one
three
major
drive
forc
mirr
trigger
signal
tabl
fig
ib
see
also
chapter
suggest
school
model
specif
blockad
interreceptor
cyto
homointeract
mirr
signal
subunit
cytotarget
agent
sitespecif
point
mutat
within
dimerizationoligomer
interfac
prevent
format
compet
signal
oligom
fig
initi
mirrmedi
cell
respons
similar
target
intramirr
tm
interact
modul
intermirr
homointeract
particular
signal
cytoplasm
domain
might
allow
us
modul
ligandinduc
cell
respons
addit
abil
select
prevent
format
signal
oligom
particular
subunit
might
also
prove
import
tool
function
studi
mirr
peptid
deriv
small
molecul
disruptor
proteinprotein
interact
sitespecif
mutat
similar
agentsmodif
use
affect
mirr
cyto
interact
mention
importandi
contrast
tmtarget
agentaffect
mirr
still
activ
specif
antibodi
fig
stimul
cytotarget
agentaffect
mirr
specif
antibodi
trigger
cell
activ
result
mirr
trigger
gener
activ
signal
fig
thu
suggest
like
intramirr
tm
interact
interreceptor
cyto
homointeract
mirr
signal
subunit
repres
extrem
import
point
control
mirr
trigger
cell
activ
sinc
use
school
model
design
cytotarget
agent
effect
inhibit
andor
modul
mirrmedi
tm
signal
fig
see
also
chapter
power
wellcontrol
influenc
upon
mirrmedi
cell
activ
thu
control
immun
respons
relev
cytotarget
agent
particular
member
mirr
famili
readili
design
use
school
model
knowledg
structur
organ
receptor
sinc
homooligomer
mirr
signal
subunit
cyto
domain
discov
cyto
homointeract
suggest
repres
import
therapeut
target
direct
experiment
evid
report
support
hypothesi
howev
grow
line
indirect
evid
indic
import
cyto
domain
function
relev
homooligomer
receptor
vivo
demonstr
school
modeldriven
mirr
cytotarget
strategi
use
varieti
cytotarget
agent
andor
mutat
fig
technolog
feasibl
readili
appli
fundament
cunic
applic
find
mostli
relat
field
sr
trigger
tm
signal
describ
fa
tumor
necrosi
factor
tnf
receptor
superfamili
member
direcdi
trigger
apoptosi
contribut
mainten
lymphocyt
homeostasi
prevent
autoimmun
although
fasassoci
death
domain
fadd
identifi
key
intracellular
mediat
fa
signal
clear
recruit
protein
fa
death
domain
dd
lead
activ
receptor
signal
complex
recendi
ugandinduc
format
surfac
receptor
oligom
report
fa
receptor
cytoplasm
dd
sr
upon
ligand
stimul
bind
homolog
dd
adaptor
protein
fadd
homooligomer
thu
initi
caspas
signal
cascad
fig
interestingli
autoimmun
lymphoprolif
syndromelink
mutat
fa
cytoplasm
domain
impair
receptor
oligomer
inhibit
fasmedi
signal
retain
abil
interact
fadd
fig
suggest
homointeract
signal
cytoplasm
tail
play
import
role
ligandinduc
surfac
receptor
oligomer
subsequ
signal
interest
find
support
propos
mirr
cytotarget
strategi
provid
promis
direct
futur
research
one
also
hypothes
similar
mutat
locat
cyto
domain
mirr
signal
subunit
might
occur
natur
mirrmedi
disord
disturb
homooligomer
interfac
thu
prevent
format
compet
signal
subunit
oligom
mirr
trigger
grow
line
evid
indic
cyto
peptid
peptidomimet
successfiilli
use
target
cyto
heteroor
homointeract
entir
protein
molecul
cyto
domain
tm
protein
ihi
mean
identifi
new
promis
therapeut
cyto
target
technolog
feasibl
design
synthes
use
relev
peptidebas
agent
peptidomimet
small
molecul
screen
appropri
agent
use
high
throughput
screen
assay
select
exampl
cytotarget
agent
use
inhibit
cyto
proteinprotein
interact
thu
modifi
function
respons
consid
detail
myeloid
differenti
factor
critic
adaptor
protein
recruit
signal
protein
receptor
ilir
superfamili
thu
play
crucial
role
signal
pathway
trigger
receptor
innat
host
defens
critic
event
signal
pathway
homodimer
mediat
tlr
ilir
translat
initi
domain
tir
abl
heterodimer
receptor
homodimer
anoth
molecul
fig
dimer
favor
recruit
downstream
signal
molecul
two
illrassoci
kinas
irak
iraki
fig
recent
eptapeptid
mimic
bbloop
region
conserv
tir
domain
shown
effect
inhibit
homodimer
either
isol
tir
fulllength
fig
author
also
demonstr
cell
permeabl
analog
eptapeptid
inhibit
homodimer
tir
domain
vitro
cell
system
significandi
reduc
signal
indic
homodimer
interfac
good
target
specif
inhibit
signal
vivo
importandi
synthet
peptidomimet
compound
model
structur
heptapeptid
bbloop
domain
shown
recent
inhibit
dimer
coimmunoprecipit
experi
effect
specif
homodimer
tir
domain
affect
homodimer
dd
ihe
agent
caus
inhibit
ill
activ
nfkb
transcript
activ
oral
administr
compound
result
dosedepend
inhibit
ill
product
treat
mice
addit
suppress
bcell
prolifer
differenti
plasma
cell
respons
cpginduc
activ
receptor
requir
intracellular
signal
data
indic
peptidomimet
compound
studi
block
ilirtlr
signal
interf
homodimer
suggest
inhibit
homodimer
cyto
milieu
peptidebas
agent
peptidomimet
may
therapeut
potenti
treatment
chronic
inflammatori
diseas
find
strongli
support
basic
principl
school
modelsuggest
strategi
new
point
intervent
inhibitmodul
mirr
trigger
immun
respons
mirr
signal
subunit
cyto
homointeract
tmtarget
strategi
current
understand
mirr
structur
natur
specif
antigenligandinduc
homointeract
receptor
signal
subunit
allow
us
inhibit
proteinprotein
interact
also
modul
interact
sequencebas
approach
use
correspond
peptid
andor
deriv
peptidomimet
small
molecul
use
purpos
well
strengtheningweaken
andor
select
inhibit
associ
particular
signal
subunit
might
allow
us
inhibit
rather
modul
ligandinduc
cell
respons
addit
select
function
inhibit
particular
signal
subunit
repres
invalu
tool
studi
mirrmedi
tm
signal
cell
activ
anoth
exampl
process
nef
mediat
redistribut
human
monocyt
cell
consid
endocyt
mechan
use
trigger
internauz
known
involv
nef
bind
cyto
tail
target
protein
inhibit
assay
synthet
peptid
correspond
cyto
domain
demonstr
inhibit
nef
bind
peptid
immobil
polystyren
plate
introduct
cyto
peptid
nefexpress
cell
use
chariot
reagent
c
caus
substanti
reduct
loss
respect
cell
surfac
nefexpress
cell
thu
prove
princip
feasibl
utihti
cytotarget
strategi
suggest
school
model
interestingli
unlik
wildtyp
nef
nef
mutant
shown
lose
abil
mediat
effici
intern
cellsurfac
bind
cyto
peptid
mention
mutat
conserv
residu
affect
abil
nef
form
dimer
result
impair
nef
biolog
frmction
mhc
class
downmodul
enhanc
viral
infect
indic
ougomer
nef
may
critic
multipl
fimction
regard
suggest
impair
function
nef
mutant
regard
downmodul
explain
inabl
form
ougom
true
mean
ration
design
antivir
agent
abl
target
cyto
homointeract
nef
ougom
may
repres
attract
target
cyto
miueu
regard
nefmedi
modul
tcr
trigger
tm
signaung
also
respect
nef
biolog
frmction
peptidebas
cytotarget
strategi
also
success
appli
modul
outsidein
tm
signal
mediat
platelet
receptor
gpibixv
gpiib
megakaryocyteand
plateletspecif
integrin
platelet
gpibix
receptor
play
key
role
platelet
adhes
site
vascular
damag
interact
subendotheualbound
von
wiuebrand
factor
vwf
howev
despit
crucial
role
gpibixa
receptor
complex
play
hemostasi
molecular
mechan
signaung
complet
understood
gpibixa
complex
consist
four
subunit
name
gpiba
gpibp
gpix
gpv
amino
acid
sequenc
cyto
domain
gpibp
subunit
residu
shown
highli
conserv
across
speci
play
import
physiolog
role
also
report
synthet
cytotarget
agent
ceuperm
palmityl
peptid
correspond
sequenc
complet
inhibit
lowdos
thrombinand
ristocetininduc
aggreg
wash
platelet
significantli
reduc
thromboxan
txa
product
platelet
stimul
thrombin
compar
couagen
substantiauy
decreas
activ
integrin
respons
thrombin
significantli
reduc
adhes
wash
platelet
vwf
static
condit
veloc
platelet
rolung
vwf
demonstr
effect
impact
peptidebas
cytotarget
agent
platelet
frmction
term
rou
veloc
adhes
spread
signaung
aegat
integrin
play
import
role
hemostasi
mediat
platelet
adhes
aggreg
bidirect
signal
litd
known
molecular
mechan
underli
regul
allbmedi
outsidein
signal
recendi
shown
signal
enhanc
platelet
patient
lack
termin
residu
cyto
domain
detect
thromboxan
product
granul
secret
requir
ugand
crosslink
platelet
aggreg
synthet
cytotarget
agent
ceuperm
palmityl
peptid
correspond
cyto
sequenc
demonstr
effect
specif
inhibit
outsidein
signal
thu
support
basic
principl
feasibl
school
modelsuggest
cytotarget
strategi
integrin
subunit
known
contain
highli
conserv
kxgffkr
motif
cyto
domain
play
crucial
role
regul
integrin
affin
ugand
synthet
cytotarget
agent
palmityl
peptid
correspond
sequenc
cyto
domain
platelet
integrin
gpiib
allb
subimit
shown
specificauy
induc
platelet
activ
aggreg
equival
strong
agonist
thrombin
author
conclud
upidmodifi
peptid
imit
cyto
domain
gpiib
highli
specif
effect
manner
initi
parauel
independ
signal
pathway
one
lead
ligand
bind
platelet
aggreg
intracellular
signal
event
synthesi
secret
exampl
use
synthet
peptid
inhibit
proteinprotein
homointeract
intracellular
milieu
recent
report
studi
ebola
viru
ebov
filoviru
caus
sporad
outbreak
fatal
hemorrhag
fever
africa
viral
protein
one
seven
structur
protein
envelop
viru
constitu
nucleocapsid
repres
ebovspecif
transcript
activ
factor
essenti
role
homooligomer
function
signific
selfassembl
viral
transcript
propag
recent
report
interestingli
also
shown
homooligomer
dose
depend
inhibit
peptid
deriv
presum
oligomer
interfac
importantli
peptid
transfect
ebovinfect
cell
peptid
inhibit
viral
replic
suggest
inhibit
oligomer
repres
target
ebov
antivir
confirm
propos
school
model
mirrmedi
tm
signal
cell
activ
proteinprotein
homodimerizationhomooligomer
interfac
repres
import
point
intervent
cyto
milieu
target
synthet
peptid
deriv
peptidomimet
anoth
potenti
applic
cytotarget
strategi
involv
use
cytotarget
agent
modul
signal
receptor
activ
monophosphoryl
lipid
deriv
activ
moieti
lipid
bacteri
endotoxin
lipopolysaccharid
lp
recent
demonstr
lp
bind
secret
glycoprotein
turn
bind
induc
aggreg
signal
transduct
also
shown
form
homodim
despit
monom
dimer
abl
activ
nfkb
activ
significantli
enhanc
upon
homodimer
howev
nfkb
activ
monom
homodim
complet
inhibit
domin
neg
suggest
homodim
monom
activ
nfkb
differ
mechan
use
protein
complement
assay
novel
method
detect
proteinprotein
interact
vivo
homodimer
shown
mediat
cyto
domain
suggest
similar
applic
mention
cytotarget
agent
use
modul
signal
cell
activ
thu
modul
host
immun
respons
lp
despit
numer
model
mirr
signal
suggest
particular
mirr
grow
interest
target
mirr
signal
potenti
treatment
strategi
mani
immun
disord
molecular
mechan
underli
mirr
trigger
subsequ
tm
signal
transduct
unknown
long
time
prevent
improv
understand
fundament
import
process
therefor
develop
novel
pharmacolog
approach
discoveri
unusu
uniqu
biophys
phenomenon
exist
specif
homointeract
intrins
disord
cyto
domain
mirr
signal
subunit
defin
last
piec
puzzl
mirr
trigger
tm
signal
led
develop
gener
model
mirrmedi
immun
cell
activ
school
model
suggest
mirr
trigger
outcom
ligandinduc
interplay
three
major
drive
forc
repres
welldefin
proteinprotein
interact
strikingli
fall
within
similar
micromolar
affin
rang
character
rel
rapid
kinet
model
final
unravel
longstand
mysteri
mirrmedi
tm
signal
transduct
importandi
assum
molecular
mechan
underli
tm
signal
cell
activ
mediat
receptor
belong
mirr
famili
similar
school
model
readili
appli
particular
member
receptor
famili
model
suggest
molecular
mechan
vast
major
unexplain
immunolog
observ
accumul
date
see
also
chapter
reveal
novel
univers
therapeut
target
divers
varieti
disord
mediat
immun
cell
thu
open
new
horizon
fundament
clinic
research
differ
field
immunolog
structur
biolog
virolog
hematolog
other
central
hypothesi
similar
struaural
architectur
mirr
dictat
similar
mechan
mirr
trier
subsequ
signaung
cell
activ
therefor
suest
exist
similar
therapeut
target
seemingli
unrel
diseas
make
possibl
develop
novel
pharmacolog
approach
well
transfer
clinic
knowledg
experi
therapeut
strategi
variou
immun
disord
addit
hypothesi
significantli
improv
understand
immunomodulatori
activ
mani
human
virus
thu
lesson
learn
school
model
viral
pathogenesi
indic
gener
drug
design
approach
may
use
treat
varieti
differ
seemingli
unrel
inmiun
diseas
model
unravel
strike
similar
molecular
mechan
underli
immunomodulatori
aaiviti
tcr
tm
peptid
first
introduc
manolio
et
al
viral
fusion
peptid
appear
use
differ
virus
entri
target
cell
also
modul
escap
host
immun
respons
siest
possibl
design
synthes
appli
highli
specif
effect
therapeut
agent
strongli
support
feasibl
util
fundament
clinic
import
tmtarget
strategi
suggest
school
model
applic
model
platelet
collagen
receptor
gpvi
alreadi
result
develop
novel
concept
platelet
inhibit
invent
novel
platelet
inhibitor
importandi
similar
basic
principl
base
current
knowledg
structur
assembl
mirr
molecular
mechan
mirr
signal
suggest
school
model
use
explain
immunomodulatori
activ
tcr
tm
peptid
design
synthes
appli
new
gpvitarget
platelet
inhibitor
within
model
similar
approach
appli
particular
receptor
mirr
famili
therefor
diseas
medic
condit
mediat
receptor
comprehens
exampl
usabl
predict
power
school
model
also
support
central
hypothesi
context
abil
develop
gener
pharmacolog
approach
transfer
clinic
knowledg
experi
therapeut
strategi
seemingli
dispar
immunemedi
diseas
summari
would
like
highlight
school
model
describ
chapter
detail
provid
set
basic
principl
underli
mirrmedi
signal
indic
gener
drug
design
approach
could
use
treat
mani
differ
seemingli
unrel
immun
diseas
consid
multipuc
divers
mirr
involv
pathogenesi
numer
human
diseas
propos
model
contribut
significantli
improv
exist
therapi
design
new
therapeut
strategi
malign
divers
immun
system
disord
includ
infect
caus
variou
virus
mirrmedi
medic
condit
